Microfluidic spun chitosan fibers improve cell compatibility in engineered tissues, suggesting new applications for scaffolds.
Microfluidic spun hydrogel fibers are appealing for tissue engineering and cell transplantation applications because they can feature hierarchical organization, have the ability to be woven or self-assembled into macro-objects, and can be easily functionalized or used for cell or chemical encapsulation. They have been developed as templates for reconstructing fiber-shaped tissues and mimic blood vessels, muscle fibers or neural networks in vivo. Alginates are overwhelmingly employed its core material to fabricate continuous hydrogel microfiber substrates, because of the simplicity of their processing. They, however, suffer from poor cell adherence and weak cell-matrix interactions. Alginates also need crosslinking, and thus easily lose shape and leach ions in the physiological environment. To overcome these challenges, we are reporting herein the first synthesis of pure chitosan fibers by microfluidics, avoiding the use of any crosslinking agent. These fibers have smooth surfaces and excellent cell viability of 85%, in the absence of any special coating, and a comparatively higher mechanical strength (695 MPa) than known alginate ones (2-4MPa). Our system also demonstrated the synthesis of chitin nanocrystals/chitosan composite microfibers with a smooth surface and crystals visible in the cross-section. Chitosan is a natural biopolymer obtained from the deacetylation of chitin, which is found in crustacean shells, insect cuticles, and fungi, and thus represents a sustainable source. Therefore, working with chitosan-derived materials helps us to address United Nations Sustainable Development Goals (UN SDGs) 6 and 14. The fibers of pure chitosan and chitosan composite exhibit high processability and can be woven into a variety of structures. These micro structured chitosan fibers have the potential to be used as templates to create fiber-shaped tissues or to develop into live building blocks for the assembly of very complex artificial tissues.
No takes yet. Share an insight, caveat, or question.
Kaur et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: